Filing Details
- Accession Number:
- 0001127602-20-028994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-13 16:37:40
- Reporting Period:
- 2020-11-11
- Accepted Time:
- 2020-11-13 16:37:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1287981 | Jed John Kennedy | C/O Conmed Corporation 525 French Road Utica NY 13502 | Vp Gm Cet | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-11 | 4,880 | $51.30 | 10,489 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-11 | 3,291 | $95.17 | 7,198 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2020-11-11 | 4,940 | $39.87 | 12,138 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-11 | 4,564 | $94.79 | 7,574 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-11 | 376 | $95.52 | 7,198 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-11 | 5,000 | $41.93 | 12,198 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-11 | 5,000 | $94.75 | 7,198 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-11 | 5,400 | $59.96 | 12,598 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-11 | 5,400 | $94.76 | 7,198 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-11 | 1,900 | $78.76 | 9,098 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-11 | 1,900 | $95.10 | 7,198 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2020-11-11 | 4,880 | $0.00 | 4,880 | $51.30 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2020-11-11 | 4,940 | $0.00 | 4,940 | $39.87 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2020-11-11 | 5,000 | $0.00 | 5,000 | $41.93 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2020-11-11 | 5,400 | $0.00 | 5,400 | $59.96 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2020-11-11 | 1,900 | $0.00 | 1,900 | $78.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-02-27 | No | 4 | M | Direct | |
| 4,940 | 2026-03-01 | No | 4 | M | Direct | |
| 10,000 | 2027-03-01 | No | 4 | M | Direct | |
| 16,200 | 2028-03-01 | No | 4 | M | Direct | |
| 7,600 | 2029-03-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.50 to $95.48. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.51 to $95.52. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.50 to $95.375. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.50 to $95.44. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.87 to $95.375. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.
- The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period
- The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Billionaire Hedge Funds
